Evidence map›Paper›PMID 35095996›Full record

ArticleFrontiers in genetics2021

Role of

P Porras-Quesada, J M González-Cabezuelo, V Sánchez-Conde, I Puche-Sanz, V Arenas-Rodríguez, C García-López, J F Flores-Martín, J M Molina-Hernández, M J Álvarez-Cubero, L J Martínez-González and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

P Porras-QuesadaCentre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain.
J M González-CabezueloResearch and Development Department, Meridiem Seeds, Almería, Spain.
V Sánchez-CondeUrology Department, University Hospital Virgen de las Nieves, Granada, Spain.
I Puche-SanzUrology Department, University Hospital Virgen de las Nieves, Granada, Spain.
V Arenas-RodríguezCentre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain.
C García-LópezPathological Anatomy Service, University Hospital Virgen de las Nieves, Granada, Spain.
J F Flores-MartínUrology Department, University Hospital of Jaen, Jaen, Spain.
J M Molina-HernándezUrology Department, University Hospital Torrecárdenas, Almería, Spain.
M J Álvarez-CuberoCentre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain.
L J Martínez-GonzálezCentre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain.
F Vázquez-AlonsoUrology Department, University Hospital Virgen de las Nieves, Granada, Spain.
Hospital Universitario Virgen de las Nieves · ESPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESComplejo Hospitalario Torrecárdenas · ESInstituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate Cancer (PC) is commonly known as one of the most frequent tumors among males. A significant problem of this tumor is that in early stages most of the cases course as indolent forms, so an active surveillance will anticipate the appearance of aggressive stages. One of the main strategies in medical and biomedical research is to find non-invasive biomarkers for improving monitoring and performing a more precise follow-up of diseases like PC. Here we report the relevant role of

Indexed as

biomarkerexpression patternsIGF2miR-93-5pmiRNAprecision medicineprostate cancer

Identifiers

PMID35095996
PMCPMC8790605
OpenAlexW4205473022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.